ADU-1805 drug page Clinical trials

Trials with ADU-1805

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

1Trials
1Recruiting
3Countries
130Planned patients

Showing 1–1 of 1

Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
Recruiting Phase 1 130 patients NCT05856981

This first-in-human, open-label, multicenter, multi-arm dose-escalation study is designed to evaluate the safety, PK, and PD of ADU-1805, an anti- SIRPα monoclonal antibody, as monotherapy and in combination with pembrolizumab (anti-PD-1 a…

United States, Belgium, Spain Apr 2023 – Jul 2027 Interventional
Combined with: Pembrolizumab

Where the recruiting trials are